The experience of oxalate nephrolithiasis therapy by sodium pyrophosphate in experiment
https://doi.org/10.20538/1682-0363-2011-1-32-37
Abstract
The aim of the investigation was studying sodium pyrophosphate’s effect on experimental oxalate nephrolithiasis.
Experimental nephrolithiasis modeling by using of 1% ethylenglycole’s solution as a drink for rats during 6 weeks. First group was control. In the second group since the third week was being administrated sodium pyrophosphate in dose 2 g/kg. Was detecting parameters of kidney’s function, markers enzymes activity, was carried out morphological researches.
It was concluded that sodium pyrophosphate’s therapy reduce experimental oxalate nephrolithiasis.
About the Authors
A. Yu. ZharikovRussian Federation
Ya. F. Zverev
Russian Federation
V. V. Lampatov
Russian Federation
V. M. Bryukhanov
Russian Federation
O. V. Azarova
Russian Federation
O. S. Talalayeva
Russian Federation
A. V. Kudinov
Russian Federation
Yu. G. Motin
Russian Federation
References
1. Брюханов В.М., Зверев Я.Ф., Лампатов В.В. и др. Функция почек в условиях экспериментального оксалатного нефролитиаза//Нефрология. 2008. Т. 12, № 1. С. 69-74.
2. Голованова О.А., Борбат В.Ф. Почечные камни. М.: Мед. книга, 2005. 172 с.
3. Жариков А.Ю., Брюханов В.М., Зверев Я.Ф., Лампатов В.В. Современные методы моделирования оксалатного нефролитиаза//Нефрология. 2008. Т. 12, № 4. С. 28-35.
4. Жариков А.Ю., Брюханов В.М., Зверев Я.Ф., Лампатов В.В. Современные представления о модуляторах оксалатного нефролитиаза. I. Стимуляторы кристаллизации // Нефрология. 2009. Т. 13, № 1. С. 56-72.
5. Жариков А.Ю., Зверев Я.Ф., Брюханов В.М., Лампатов В.В. Механизм формирования кристаллов при оксалатном нефролитиазе//Нефрология. 2009. Т. 13, № 4. С. 37-50.
6. Зверев Я.Ф., Брюханов В.М., Лампатов В.В., Жариков А.Ю. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза//Нефрология. 2009. Т. 13, № 1. С. 39-50.
7. Тиктинский О.Л., Александров В.П. Мочекаменная болезнь. СПб.: Питер, 2000. 384 c.
8. Fleisch H., Bisaz S. Isolation from urine of pyrophosphate, a calcification inhibitor//Am. J. Physiol. 1962. V. 203. P. 671-675.
9. Grases F., Ramis M., Costa-Bauza A. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates // Urol. Res. 2000. V. 28, № 2. P. 136-140.
10. Jung A., Bisaz S., Fleisch H. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals//Calcif. Tissue Res. 1973. V. 11. P. 269-280.
11. Laminski N.A., Meyers A.M., Sonnekus M.I., Smyth A.E. Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities//Nephron. 1990. V. 56. P. 379-386.
12. Moochhala S.H., Sayer J.A., Carr A., Simmons N.L. Renal calcium stones: insights from the control of bone mineralization//Exp. Physiol. 2008. V. 93, № 1. P. 43-49.
13. Roberts N.B., Dutton J., Helliwell T. et al. Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease//Ann. Clin. Biochem. 1992. V. 29. P. 529-534.
14. Russell R.G. Metabolism of inorganic pyrophosphate (PPi)//Arthritis Rheum. 1976. V. 19, Suppl. 3. P. 465-478.
15. Wikström B., Danielson B.G., Ljunghall S. et al. Urinary pyrophosphate excretion in renal stone formers with normal and impaired renal acidification//World J. Urol. 1983. V. 1. P. 150-154.
Review
For citations:
Zharikov A.Yu., Zverev Ya.F., Lampatov V.V., Bryukhanov V.M., Azarova O.V., Talalayeva O.S., Kudinov A.V., Motin Yu.G. The experience of oxalate nephrolithiasis therapy by sodium pyrophosphate in experiment. Bulletin of Siberian Medicine. 2011;10(1):32-37. (In Russ.) https://doi.org/10.20538/1682-0363-2011-1-32-37